Growth Metrics

CVRx (CVRX) Current Leases (2022 - 2026)

CVRx's quarterly Current Leases came in at $361000.0 in Q1 2026, up 24.48% year-on-year from $290000.0 in Q1 2025, and up 2.56% quarter-over-quarter from $352000.0 in Q4 2025.

CVRx has reported Current Leases for 5 years, with the latest figure at $361000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Current Leases rose 24.48% year-over-year to $361000.0; the trailing twelve-month figure through Mar 2026 stood at $361000.0 (up 24.48% YoY), and the FY2025 full-year result was $352000.0, up 24.82% from the prior year.
  • Current Leases for Q1 2026 stood at $361000.0, up from $352000.0 in the prior quarter.
  • The five-year high for Current Leases was $361000.0 in Q1 2026, with the low at $170000.0 in Q3 2023.
  • Average Current Leases over 5 years is $264266.7, with a median of $247000.0 recorded in 2024.
  • Year-over-year, Current Leases grew 4.05% in 2023 and surged 61.76% in 2024.
  • Tracing CVRX's Current Leases over 5 years: stood at $222000.0 in 2022, then gained by 4.05% to $231000.0 in 2023, then advanced by 22.08% to $282000.0 in 2024, then gained by 24.82% to $352000.0 in 2025, then advanced by 2.56% to $361000.0 in 2026.
  • The last three Current Leases figures came in at $361000.0 (Q1 2026), $352000.0 (Q4 2025), and $342000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 24.30 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 20.50 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 35.80 Mn
10 CVRx 144.43 Mn 72.13 Mn 12.88 Mn 361,000.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 361,000.00
Dec 31, 2025 352,000.00
Sep 30, 2025 342,000.00
Jun 30, 2025 333,000.00
Mar 31, 2025 290,000.00
Dec 31, 2024 282,000.00
Sep 30, 2024 275,000.00
Jun 30, 2024 247,000.00
Mar 31, 2024 239,000.00
Dec 31, 2023 231,000.00
Sep 30, 2023 170,000.00
Jun 30, 2023 185,000.00
Mar 31, 2023 227,000.00
Dec 31, 2022 222,000.00
Mar 31, 2022 208,000.00